Details
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Full-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPORanked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 2 · Follow-on 0
Stages: Undisclosed 2
Full-Life Technologies $150M Series D+DebtOricell Therapeutics $110M Pre-IPONew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 1 · Follow-on 1
Stages: Growth 1, Undisclosed 1
ROBOTERA $200M GrowthROBOTERA CN¥1B StrategicNew companies 2 · Follow-on 0
Stages: Series A 1, Series B 1
Vivacta Biotechnology $50M Series A+Syneron Bio $150M Series BNew companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 1 · Follow-on 1
Stages: Series C+ 1, Undisclosed 1
Oricell Therapeutics $110M Pre-IPOOricell Therapeutics $70M Series C1New companies 2 · Follow-on 0
Stages: Seed 1, Series B 1
Syneron Bio $150M Series BExcalipoint Therapeutics $27.7M Seed+New companies 1 · Follow-on 0
Stages: Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreementNew companies 1 · Follow-on 0
Stages: Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreementNew companies 1 · Follow-on 0
Stages: Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreementNew companies 1 · Follow-on 0
Stages: Undisclosed 1
MHX Technology CN¥1.6B First equity financing agreement“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.